<?xml version='1.0' encoding='utf-8'?>
<document id="30233359"><sentence text="Potential Metabolic Drug-Drug Interaction of Citrus aurantium L. (Rutaceae) Evaluating by Its Effect on 3 CYP450." /><sentence text="Aim:Fructus aurantii (FA) is widely used in clinic as an expectorant and digestant herb in traditional Chinese medicine and proven to have a variety of pharmacological functions" /><sentence text=" FA is close to grapefruit either by botanical taxonomy or by their same components (flavonoids, etc"><entity charOffset="1-3" id="DDI-PubMed.30233359.s3.e0" text="FA" /><entity charOffset="85-95" id="DDI-PubMed.30233359.s3.e1" text="flavonoids" /><pair ddi="false" e1="DDI-PubMed.30233359.s3.e0" e2="DDI-PubMed.30233359.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30233359.s3.e0" e2="DDI-PubMed.30233359.s3.e1" /></sentence><sentence text=") and grapefruit has been proven to cause drug-drug interaction when co-administrated with CYP3A4 substrates" /><sentence text=" Besides, FA contains many compounds, such as flavonoids, which have been reported to impact the expressions of CYP450"><entity charOffset="10-12" id="DDI-PubMed.30233359.s5.e0" text="FA" /><entity charOffset="46-56" id="DDI-PubMed.30233359.s5.e1" text="flavonoids" /><pair ddi="false" e1="DDI-PubMed.30233359.s5.e0" e2="DDI-PubMed.30233359.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30233359.s5.e0" e2="DDI-PubMed.30233359.s5.e1" /></sentence><sentence text=" However, the effect of FA on CYP450, whose change may affect drug safety and clinical efficacy attributed to drug-drug interaction, still remains unknown"><entity charOffset="24-26" id="DDI-PubMed.30233359.s6.e0" text="FA" /></sentence><sentence text=" Methods: The protein, mRNA expression and enzyme activity of CYP1A2, CYP3A4, and CYP2E1 in rat were determined by Western Blotting, RT-PCR method, the cocktail method, respectively, after orally administration of FA in succession for 7 days"><entity charOffset="214-216" id="DDI-PubMed.30233359.s7.e0" text="FA" /></sentence><sentence text=" CYP1A2, CYP3A4, and CYP2E1 mRNA expression were investigated in HepG2 cells following FA-medicated serum incubation for 24 h"><entity charOffset="87-88" id="DDI-PubMed.30233359.s8.e0" text="FA" /></sentence><sentence text=" Results: In rat, compared to the control group, CYP1A2, CYP3A4 protein, and mRNA expression were significantly induced consistent with the corresponding CYP activities; the protein expression of CYP2E1 was significantly upregulated, while the corresponding mRNA expression and enzyme activity showed no significant change" /><sentence text=" In HepG2 cells, compared to the control group, the mRNA expression of CYP1A2 and CYP3A4 was up-regulated statistically while CYP2E1 mRNA expression was not significantly induced or inhibited" /><sentence text=" Conclusion: FA may be a potential slight inducer of CYP1A2 and CYP3A4 and is unlikely to impact CYP2E1 until clinical researches are conducted"><entity charOffset="13-15" id="DDI-PubMed.30233359.s11.e0" text="FA" /></sentence><sentence text="" /></document>